Both in Pharmaceuticals
Obsidian Therapeutics vs Alto Neuroscience
Over the past year OBX returned −16.9% and ANRO returned −29.4%; their daily moves had a correlation of 0.49.
OBX −16.9% ANRO −29.4%Growth of $1, one year, split-adjusted
| Metric | OBX | ANRO |
|---|---|---|
| Price | $14.79 | $22.60 |
| Market cap | $913.6M | $886.9M |
| Today | +1.86% | −3.71% |
| 1 month | +11.0% | −10.7% |
| 6 months | — | −9.4% |
| Year to date | — | +27.0% |
| 1 year | — | +61.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 56.0% |
| Short % of float | 2.2% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).